929O_PR ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis
dc.contributor.author | Clamp, Andrew R | |
dc.contributor.author | McNeish, I | |
dc.contributor.author | Dean, A | |
dc.contributor.author | Gallardo, D | |
dc.contributor.author | Weon-Kim, J | |
dc.contributor.author | O'Donnell, D | |
dc.contributor.author | Hook, J | |
dc.contributor.author | Coyle, C | |
dc.contributor.author | Blagden, S | |
dc.contributor.author | Brenton, J | |
dc.contributor.author | Naik, R | |
dc.contributor.author | Perren, T | |
dc.contributor.author | Sundar, S | |
dc.contributor.author | Cook, A | |
dc.contributor.author | James, E | |
dc.contributor.author | Swart, A | |
dc.contributor.author | Stenning, S | |
dc.contributor.author | Kaplan, R | |
dc.contributor.author | Ledermann, J | |
dc.date.accessioned | 2017-11-21T21:33:02Z | |
dc.date.available | 2017-11-21T21:33:02Z | |
dc.date.issued | 2017-09 | |
dc.identifier.citation | 929O_PRICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis 2017, 28(suppl_5): Ann Oncol | en |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdx440.039 | |
dc.identifier.uri | http://hdl.handle.net/10541/620638 | |
dc.language.iso | en | en |
dc.relation.url | http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx440.039/4109951/929OPRICON8-A-GCIG-phase-III-randomised-trial | en |
dc.rights | Archived with thanks to Annals of Oncology | en |
dc.title | 929O_PR ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK | en |
dc.identifier.journal | Annals of Oncology | en |